Boxer Capital as of March 31, 2018
Portfolio Holdings for Boxer Capital
Boxer Capital holds 33 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Avexis | 11.9 | $111M | 900k | 123.58 | |
Beigene (BGNE) | 11.3 | $106M | 630k | 168.00 | |
Ptc Therapeutics I (PTCT) | 7.5 | $70M | 2.6M | 26.99 | |
Esperion Therapeutics (ESPR) | 7.0 | $65M | 900k | 72.33 | |
Odonate Therapeutics Ord | 6.4 | $60M | 2.8M | 21.18 | |
Macrogenics (MGNX) | 5.9 | $55M | 2.2M | 25.16 | |
Wave Life Sciences (WVE) | 5.8 | $54M | 1.4M | 40.05 | |
Loxo Oncology | 4.9 | $46M | 400k | 115.37 | |
Mirati Therapeutics | 4.5 | $42M | 1.4M | 30.70 | |
Medicines Company | 4.4 | $41M | 1.3M | 32.94 | |
Rocket Pharmaceuticals (RCKT) | 3.9 | $37M | 2.0M | 18.75 | |
Cymabay Therapeutics | 3.8 | $35M | 2.7M | 12.99 | |
Gtx Inc Del | 3.0 | $28M | 1.6M | 17.75 | |
G1 Therapeutics (GTHX) | 2.6 | $25M | 660k | 37.05 | |
Dbv Technologies S A (DBVT) | 2.5 | $24M | 1.0M | 23.07 | |
Blueprint Medicines (BPMC) | 2.5 | $23M | 250k | 91.70 | |
Rigel Pharmaceuticals (RIGL) | 1.9 | $18M | 5.1M | 3.54 | |
Kura Oncology (KURA) | 1.7 | $16M | 845k | 18.75 | |
Viking Therapeutics (VKTX) | 1.5 | $14M | 3.2M | 4.37 | |
Ionis Pharmaceuticals (IONS) | 1.5 | $14M | 312k | 44.08 | |
Aquinox Pharmaceuticals | 1.1 | $11M | 748k | 14.08 | |
La Jolla Pharmaceuticl Com Par | 0.8 | $8.0M | 268k | 29.78 | |
Reata Pharmaceuticals Inc Cl A | 0.7 | $6.7M | 325k | 20.51 | |
Sunesis Pharmaceuticals Inc Ne | 0.6 | $5.8M | 2.1M | 2.72 | |
Solid Biosciences | 0.6 | $5.6M | 750k | 7.50 | |
Dermira | 0.4 | $4.0M | 500k | 7.99 | |
Bellerophon Therapeutics | 0.4 | $3.9M | 1.9M | 2.08 | |
Bellicum Pharma | 0.2 | $2.3M | 350k | 6.56 | |
Rigel Pharmaceuticals Inc cmn | 0.2 | $1.8M | 500k | 3.54 | |
Novus Therapeutics | 0.2 | $1.6M | 324k | 5.04 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $1.4M | 100k | 14.23 | |
Regulus Therapeutics | 0.1 | $1.2M | 1.7M | 0.72 | |
Onconova Therapeutics Inc *w exp 07/07/202 | 0.0 | $73k | 242k | 0.30 |